Find the Perfect Plan for Your Investment Journey
Latest price
52 Week Range
$55.00 - $177.37
Next Earnings Date
Apr 29 2025
Next Earnings Date
Apr 29 2025
Latest price
Market Cap | $3.12B |
EV | $3.30B |
Shares Outstanding | 35.43M |
Beta | 2.13 |
Analyst Rating | OUTPERFORM |
Analyst Target Price | $103.14 |
P/E 2025E | 61.31x |
P/Revenue 2025E | 5.77x |
Revenue | 144.40% |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | -35.70% |
Revenue | 19.60% |
EPS | 47.50% |
Operating Cash Flow | 50.40% |
Free Cash Flow | - |
Gross Margin 2025E | 60.34% |
Net Profit Margin 2025E | 9.82% |
ROE 2025E | 16.72% |
ROCE 2024 | 19.39% |
DPS 2025E | - |
Payout Ratio 2025E | - |
Div. Yield 2025E | - |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
TransMedics Group, Inc.
TMDX
Sector
Healthcare
Industry
Medical - Devices
CEO
Hassanein, Waleed
Employees
728
Website
www.transmedics.comIPO Date
2019-05-02
Headquarters
200 Minuteman Road, Suite 302, Andover, Massachusetts, 01810, United States
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved